129 related articles for article (PubMed ID: 6268885)
1. Determinants of susceptibility and resistance to feline leukemia virus infection. I. Role of macrophages.
Hoover EA; Rojko JL; Wilson PL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):889-98. PubMed ID: 6268885
[TBL] [Abstract][Full Text] [Related]
2. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
3. Feline leukemia virus infection: age-related variation in response of cats to experimental infection.
Hoover EA; Olsen RG; Hardy WD; Schaller JP; Mathes LE
J Natl Cancer Inst; 1976 Aug; 57(2):365-9. PubMed ID: 187771
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.
Beebe AM; Faith TG; Sparger EE; Torten M; Pedersen NC; Dandekar S
AIDS; 1994 Jul; 8(7):873-8. PubMed ID: 7946095
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of feline leukemia virus-induced leukemogenesis in cats exposed to methylnitrosourea.
Schaller JP; Mathes LE; Hoover EA; Olsen RG
Int J Cancer; 1979 Nov; 24(5):700-5. PubMed ID: 93586
[TBL] [Abstract][Full Text] [Related]
6. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection.
Rojko JL; Hoover EA; Mathes LE; Krakowka S; Olsen RG
Cancer Res; 1979 Sep; 39(9):3789-91. PubMed ID: 225025
[TBL] [Abstract][Full Text] [Related]
7. Natural feline leukemia virus infection and the immune response of cats of different ages.
Grant CK; Essex M; Gardner MB; Hardy WD
Cancer Res; 1980 Mar; 40(3):823-9. PubMed ID: 6258787
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of latent feline leukaemia virus infection.
Rojko JL; Hoover EA; Quackenbush SL; Olsen RG
Nature; 1982 Jul; 298(5872):385-8. PubMed ID: 6283387
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.
Polas PJ; Swenson CL; Sams R; Cheney CM; Hayes KA; Tarr MJ; Kociba GJ; Mathes LE
Antimicrob Agents Chemother; 1990 Jul; 34(7):1414-21. PubMed ID: 2167039
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
[TBL] [Abstract][Full Text] [Related]
11. Study of feline leukemia virus immunity.
Charreyre C; Pedersen NC
J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
[TBL] [Abstract][Full Text] [Related]
12. Recombinant feline leukemia virus (FeLV) variants establish a limited infection with altered cell tropism in specific-pathogen-free cats in the absence of FeLV subgroup A helper virus.
Bechtel MK; Hayes KA; Mathes LE; Pandey R; Stromberg PC; Roy-Burman P
Vet Pathol; 1999 Mar; 36(2):91-9. PubMed ID: 10098636
[TBL] [Abstract][Full Text] [Related]
13. Interaction between feline leukaemia virus subgroups in the pathogenesis of erythroid hypoplasia.
Jarrett O; Golder MC; Toth S; Onions DE; Stewart MF
Int J Cancer; 1984 Aug; 34(2):283-8. PubMed ID: 6088406
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection.
Lehmann R; Joller H; Haagmans BL; Lutz H
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):61-9. PubMed ID: 1337403
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy studies of live- and killed-feline leukemia virus vaccines.
Pedersen NC; Theilen GH; Werner LL
Am J Vet Res; 1979 Aug; 40(8):1120-6. PubMed ID: 230767
[TBL] [Abstract][Full Text] [Related]
16. Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household.
Essex M; Cotter SM; Sliski AH; Hardy WD; Stephenson JR; Aaronson SA; Jarrett O
Int J Cancer; 1977 Jan; 19(1):90-6. PubMed ID: 188773
[TBL] [Abstract][Full Text] [Related]
17. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
[TBL] [Abstract][Full Text] [Related]
18. Passive immunity to feline leukemia: evaluation of immunity from dams naturally infected and experimentally vaccinated.
Hoover EA; Schaller JP; Mathes LE; Olsen RG
Infect Immun; 1977 Apr; 16(1):54-9. PubMed ID: 194840
[TBL] [Abstract][Full Text] [Related]
19. Feline leukemia virus infection and diseases.
Hoover EA; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1287-97. PubMed ID: 1666070
[TBL] [Abstract][Full Text] [Related]
20. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
